7 patents
Utility
Gut-selective Sequestering Agents for the Treatment and Prevention of Autism and Related Disorders
16 Nov 23
The present disclosure describes methods and compositions for the treatment of neurological disorders and related symptoms by the in vivo sequestration and excretion of microbial metabolites.
Anthony Stewart Campbell, David H. Donabedian
Filed: 30 Jun 23
Utility
Gut-selective sequestering agents for the treatment and prevention of autism and related disorders
18 May 21
The present disclosure describes methods and compositions for the treatment of neurological disorders and related symptoms by the in vivo sequestration and excretion of microbial metabolites.
Anthony Stewart Campbell, David H. Donabedian
Filed: 10 Jun 20
Utility
Gut-selective Sequestering Agents for the Treatment and Prevention of Autism and Related Disorders
16 Dec 20
The present disclosure describes methods and compositions for the treatment of neurological disorders and related symptoms by the in vivo sequestration and excretion of microbial metabolites.
Anthony Stewart Campbell, David H. Donabedian
Filed: 22 Mar 20
Utility
Gut-selective Sequestering Agents for the Treatment and Prevention of Autism and Related Disorders
25 Nov 20
The present disclosure describes methods and compositions for the treatment of neurological disorders and related symptoms by the in vivo sequestration and excretion of microbial metabolites.
Anthony Stewart Campbell, David H. Donabedian
Filed: 9 Jun 20
Utility
Inhibitors of Microbially Induced Amyloid
16 Sep 20
The present disclosure provides compounds useful for the prevention of amyloid formation and the treatment of amyloid related disorders, including synucleopathies such as Parkinson's Disease.
Anthony Stewart Campbell, Bridget Cole, Alessandra Bartolozzi
Filed: 5 Aug 18
Utility
Inhibitors of Microbially Induced Amyloid
27 May 20
The present disclosure provides methods and compositions for the prevention, amelioration, or alleviation of one or more neurological disorders associated with microbially-induced amyloid formation.
Timothy Sampson, Sarkis Mazmanian, Anthony Stewart Campbell
Filed: 13 May 18
Utility
Gut-selective sequestering agents for the treatment and prevention of autism and related disorders
13 Apr 20
The present disclosure describes methods and compositions for the treatment of neurological disorders and related symptoms by the in vivo sequestration and excretion of microbial metabolites.
Anthony Stewart Campbell, David H. Donabedian
Filed: 30 May 18
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first